
Guangdong True Health Medical Technology Development Co., Ltd.
2697.HKHKSEHealthcareMedical - Devices
最新数据
HK$777
+HK$109 · +16.32%
2697.HK公司概览
盘中时间采用HKT。市场数据可能有所延迟。
公司概况
公司网站Guangdong True Health Medical Technology Development Co., Ltd. engages in in the research and development, manufacture and sale of surgical robots and disposables in the People's Republic of China and Hong Kong. The company offers products, such as percutaneous puncture surgery robots, includes TH-S1, TH-S, TH-S Pro and TH-SA; microwave ablation surgical robot for the treatment of liver and lung tumors; percutaneous microwave ablation surgical robot TH-X HMW approved for the treatment of liver tumors; AI-based 3D reconstruction software for medical imaging; and five additional product, including the TH-P series of compact percutaneous puncture surgical robots which are approved for lung and abdominal puncture, the MW150 microwave ablation device, the TH-X Cryo cryoablation robot, the TH-LS KI300 and TH-LS LU100 ex vivo organ preservation and assessment systems. The company was formerly known as True Health (Guangdong Hengqin) Medical Technology Co., Ltd. and changed its name to Guangdong True Health Medical Technology Development Co., Ltd. in October 2025. The company was incorporated in 2018 and is based in Zhuhai, China.
- 行业
- Medical - Devices
- 部门
- Healthcare
- 总部
- CN
- 首席执行官
- Hou Iam Cheong
- 上市以来
- 2026年6月30日
- 雇员
- 156
市场位置
日内区间
当前HK$777,
52周区间
当前HK$777,
- 开盘价
- HK$668
- 前收盘价
- HK$668
- 成交量
- 4.6万
- 0.66× 平均值
- 平均成交量
- 6.92万
- 日均成交量
- 市值
- 276.98亿 HKD
- 贝塔
- -0.9
- 市场参考 1
- 50天平均值
- HK$595.88
- 高于平均水平+30.40%
- 200天平均值
- HK$595.88
- 高于平均水平+30.40%
2697.HK同业公司
继续GoAI的研究
在 GoAI 中研究2697.HKresearch.disclaimer





